Suchergebnisse - "Salazar, Ramon"

PubPharm (20)

1

VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects

enthalten in: Journal for immunotherapy of cancer | 2021

von Bazan-Peregrino, M. | Garcia-Carbonero, R. | Laquente, B. | +20

2

A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients

enthalten in: Human gene therapy | 2019

von García, M. | Moreno, R. | Gil-Martin, M. | +8

3

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

enthalten in: Journal for immunotherapy of cancer | 2019

von Machiels, J. | Salazar, R. | Rottey, S. | +11

CommentIn: J Immunother Cancer. 2019 Feb 1;7(1):26. - PMID 30709365

4

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

enthalten in: Journal for immunotherapy of cancer | 2017

von Garcia-Carbonero, R. | Salazar, R. | Duran, I. | +11

5

Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Petty, R. | Anthoney, A. | Metges, J. | +10

6

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib : results of the CNIO-BR002 phase I-trial

enthalten in: Molecular oncology | 2014

von Quintela-Fandino, M. | Bueno, M. | Lombardia, L. | +9

7

Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2014

von Salazar, R. | Calles, A. | Gil, M. | +9

8

Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Salazar, R. | Morales, S. | Gil-Martín, M. | +7

9

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

enthalten in: Medical oncology (Northwood, London, England) | 2012

von Pardo, B. | Salazar, R. | Ciruelos, E. | +9

10

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2012

von Vidal, L. | Magem, M. | Barlow, C. | +8